Brazil urged to extend tariff cuts to medical devices
This article was originally published in Clinica
Brazil has come under renewed pressure to lower taxes and tariffs on medical devices, after approving fiscal cuts that will result in an 11% drop in the OTC price of over 1,000 medicinal products. The No Taxes on Drugs and Devices Initiative (NtDDi), a Johannesburg, South Africa-based pressure group, welcomed the move, but is urging the government to go further and improve access to medical devices, as well as medicines, by cutting import duty. This, says the group, is needed to increase the Brazilian 186 million population's access to essential healthcare products.
You may also be interested in...
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.
As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.